A detailed history of Cwm, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Cwm, LLC holds 300 shares of SAVA stock, worth $758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 290 3.45%
Holding current value
$758
Previous $4,000 125.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$9.57 - $35.08 $95 - $350
10 Added 3.45%
300 $9,000
Q2 2024

Jul 09, 2024

BUY
$12.35 - $26.11 $370 - $783
30 Added 11.54%
290 $4,000
Q1 2024

Apr 05, 2024

BUY
$18.44 - $26.41 $4,794 - $6,866
260 New
260 $5,000
Q3 2023

Oct 11, 2023

SELL
$16.64 - $25.32 $4,392 - $6,684
-264 Reduced 94.96%
14 $0
Q1 2022

Apr 21, 2022

BUY
$32.6 - $53.05 $9,062 - $14,747
278 New
278 $10,000
Q4 2021

Jan 31, 2022

SELL
$36.77 - $90.91 $7,354 - $18,182
-200 Closed
0 $0
Q4 2020

Sep 15, 2021

BUY
$6.79 - $12.25 $1,358 - $2,450
200 New
200 $17,000
Q4 2020

Jan 27, 2021

SELL
$6.79 - $12.25 $1,358 - $2,450
-200 Closed
0 $0
Q3 2020

Sep 15, 2021

BUY
$2.86 - $11.51 $572 - $2,302
200 New
200 $17,000
Q3 2020

Oct 19, 2020

SELL
$2.86 - $11.51 $572 - $2,302
-200 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$2.04 - $9.64 $408 - $1,928
200 New
200 $17,000
Q2 2020

Jul 22, 2020

SELL
$2.04 - $9.64 $408 - $1,928
-200 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$3.26 - $9.65 $652 - $1,930
200 New
200 $17,000
Q1 2020

Apr 28, 2020

SELL
$3.26 - $9.65 $652 - $1,930
-200 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$1.1 - $6.12 $220 - $1,224
200 New
200 $17,000
Q4 2019

Jan 27, 2020

SELL
$1.1 - $6.12 $220 - $1,224
-200 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$1.04 - $1.45 $208 - $290
200 New
200 $17,000
Q3 2019

Oct 22, 2019

SELL
$1.04 - $1.45 $208 - $290
-200 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$1.02 - $1.34 $204 - $268
200 New
200 $17,000
Q2 2019

Jul 31, 2019

SELL
$1.02 - $1.34 $204 - $268
-200 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$0.92 - $1.29 $184 - $258
200 New
200 $0

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $101M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.